Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) Stock Price & Growth Analysis

Quote Panel

Updated July 14, 2025

1W 4.59 % 1M 14.07 % 3M 41.63 % 1Y 32.14 %

Key Metrics

Market Cap
4.16B
Shares Outstanding
703.54M
Share in Float
325.25M
Dividende
0

Earning Date
No Data
Price Target
5.92
Average Volume
19.40M
Beta
0.565

Range
3.45-9.54
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.lingkang.com.cn
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

11.82x

P/S Ratio

4.89x

P/B Ratio

0.4

Debt/Equity

-37.9%

Net Margin

$-0.2

EPS

How 603669.SS compares to sector?

P/E Ratio

Fundamentals

Relative Strength

603669.SS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.16
vs -0.02

Q1.23

N/A

-0.03
vs 0.03

Q2.23

N/A

-0.06
vs 0.02

Q3.23

N/A

-0.04
vs -0.16

Q4.23

N/A

-0.08
vs -0.16

Q1.24

N/A

-0.02
vs -0.03

Q2.24

N/A

-0.03
vs -0.06

Q3.24

N/A

-0.01
vs -0.04

Q4.24

N/A

-0.12
vs -0.08

Q1.25

N/A

-0.03
vs -0.02

Sales Growth

YoY

Current

Estimates

Q4.22

-56%

38.1M vs 86.4M

Q1.23

-42%

73.3M vs 126M

Q2.23

-47%

39.6M vs 74.3M

Q3.23

-26%

37.7M vs 50.9M

Q4.23

+21%

46.2M vs 38.1M

Q1.24

+4%

76.2M vs 73.3M

Q2.24

+61%

63.8M vs 39.6M

Q3.24

+137%

89.6M vs 37.7M

Q4.24

+222%

148.7M vs 46.2M

Q1.25

-34%

50.1M vs 76.2M

Return on Equity

QoQ

Q2.23

-4%

-0.04
vs -0.02

Q3.23

-3%

-0.03
vs -0.04

Q4.23

-6%

-0.06
vs -0.03

Q1.24

-2%

-0.02
vs -0.06

Q2.24

-3%

-0.03
vs -0.02

Q3.24

-1%

-0.01
vs -0.03

Q4.24

-11%

-0.11
vs -0.01

Q1.25

-2%

-0.02
vs -0.11

Institutionnal Ownership

Company Description

5.92CNY

N/A

11.82x

4.89x

0.4

-37.9%

$-0.2

Earnings Growth

Latest News

Company Description

5.92CNY

N/A

11.82x

4.89x

0.4

-37.9%

$-0.2